🔗 Share this article

Treasury head Rachel Reeves has revealed she is planning "focused measures to deal with cost of living pressures" in the upcoming Budget.

Speaking to media outlets, she stated that lowering price rises is a collective task of both the administration and the Bank of England.

The United Kingdom's price growth is expected to be the most elevated among the Group of Seven advanced economies this calendar year and next.

Potential Utility Cost Interventions

It is understood the administration could intervene to lower energy bills, for example by cutting the present 5% level of VAT applied on energy.

An additional approach is to reduce some of the government charges currently added to bills.

Budgetary Limitations and Analyst Predictions

The government will obtain the next draft from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much space there is for such measures.

The consensus from most experts is that Reeves will have to declare tax rises or budget cuts in order to meet her declared fiscal targets.

Previously on the same day, analysis suggested there was a £22bn deficit for the chancellor to address, which is at the lower end of expectations.

"It is a shared job between the central bank and the government to continue tackling some of the causes of inflation," the Chancellor informed the BBC in the US capital, at the conferences of the IMF and World Bank.

Tax Pledges and International Issues

While much of the focus has been on expected tax increases, the chancellor said the most recent data from the fiscal watchdog had not altered her commitment to campaign commitments not to increase rates on earnings tax, VAT or social security contributions.

She attributed an "uncertain world" with growing international and commercial issues for the Budget revenue measures, likely to be directed on those "with the broadest shoulders."

Global Economic Tensions

Addressing concerns about the United Kingdom's trade ties with the Asian nation she said: "Our security interests invariably come first."

Recent statement by Chinese authorities to increase trade restrictions on critical minerals and other resources that are crucial for high-technology manufacturing led US President Donald Trump to threaten an additional 100% tariff on imports from the Asian country, increasing the risk of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary called China's decision "economic coercion" and "a international production power grab."

Inquired about considering the US offer to join its battle with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and called on the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "bad for the international commerce and generates further challenges."

"I believe there are areas where we should challenge China, but there are also significant prospects to export to China's economy, including financial services and other areas of the economy. We've got to achieve that equilibrium appropriate."

The Treasury chief also confirmed she was working with international partners "regarding our own essential resources strategy, so that we are more independent."

Health Service Drug Pricing and Funding

Reeves also recognized that the cost the NHS pays for medicines could go up as a result of ongoing talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and capital.

A number of the world's largest drug companies have said in recent statements that they are either delaying or abandoning operations in the UK, with some attributing the low prices they are getting.

Last month, the Science Minister said the cost the NHS spends on medicines would must increase to stop companies and pharmaceutical investment leaving the UK.

The Chancellor informed media: "We have seen due to the cost structure, that clinical trials, innovative medicines have not been available in the UK in the way that they are in other European countries."

"Our aim is to make sure that people getting treatment from the National Health Service are can obtain the finest critical treatments in the globe. And so we are looking at these issues, and... seeking to secure more funding into Britain."